Exploring patient and clinician perspectives for homologous recombination deficient (HRD) biomarker testing to guide precision medicine for advanced ovarian cancer treatment: A qualitative study
Exploring patient and clinician perspectives for homologous recombination deficient (HRD) biomarker testing to guide precision medicine for advanced ovarian cancer treatment: A qualitative study. // Patient Education and Counseling. – URL: https://www.sciencedirect.com/science/article/pii/S073839912600875X?dgcid=rss_sd_all
Exploring patient and clinician perspectives for homologous recombination deficient (HRD) biomarker testing to guide precision medicine for advanced ovarian cancer treatment: A qualitative study. Patient Education and Counseling. https://www.sciencedirect.com/science/article/pii/S073839912600875X?dgcid=rss_sd_all
“Exploring patient and clinician perspectives for homologous recombination deficient (HRD) biomarker testing to guide precision medicine for advanced ovarian cancer treatment: A qualitative study.” Patient Education and Counseling.
@article{article61785,
title = {Exploring patient and clinician perspectives for homologous recombination deficient (HRD) biomarker testing to guide precision medicine for advanced ovarian cancer treatment: A qualitative study},
journal = {Patient Education and Counseling},
url = {https://www.sciencedirect.com/science/article/pii/S073839912600875X?dgcid=rss_sd_all}
}
ABSTRACT As leadership education continues to evolve, increasing attention has been given to fostering learners’ leadership identity, capacity, and efficacy. Drawing on collaborative conversations with 12 leadership educators...